omeprazole has been researched along with Carcinoma, Epidermoid in 4 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Equine gastric ulcer syndrome (EGUS) is the most common disease of the stomach in horses and treatment is based on the oral administration of omeprazole for at least 28 days." | 9.69 | A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial. ( Busechian, S; Conte, G; Conti, MB; Marchesi, MC; Pieramati, C; Rueca, F; Sgorbini, M; Vitale, V; Zappulla, F, 2023) |
| "Equine gastric ulcer syndrome (EGUS) is the most common disease of the stomach in horses and treatment is based on the oral administration of omeprazole for at least 28 days." | 5.69 | A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial. ( Busechian, S; Conte, G; Conti, MB; Marchesi, MC; Pieramati, C; Rueca, F; Sgorbini, M; Vitale, V; Zappulla, F, 2023) |
| "Esophageal squamous cell carcinoma developed in INK4a/Arf+/- mice (7." | 1.35 | Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice. ( Chen, X; Hao, J; Liu, B; Yang, CS, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sundra, T | 1 |
| Kelty, E | 1 |
| Rendle, D | 1 |
| Busechian, S | 1 |
| Conti, MB | 1 |
| Sgorbini, M | 1 |
| Conte, G | 1 |
| Marchesi, MC | 1 |
| Pieramati, C | 1 |
| Zappulla, F | 1 |
| Vitale, V | 1 |
| Rueca, F | 1 |
| Hao, J | 1 |
| Liu, B | 1 |
| Yang, CS | 1 |
| Chen, X | 1 |
| Okamura, Y | 1 |
| Takeno, S | 1 |
| Takahashi, Y | 1 |
| Moroga, T | 1 |
| Yamashita, S | 1 |
| Kawahara, K | 1 |
1 trial available for omeprazole and Carcinoma, Epidermoid
| Article | Year |
|---|---|
A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial.
Topics: Animals; Anti-Ulcer Agents; Carcinoma, Squamous Cell; Horse Diseases; Horses; Omeprazole; Powders; S | 2023 |
3 other studies available for omeprazole and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Five- versus seven-day dosing intervals of extended-release injectable omeprazole in the treatment of equine squamous and glandular gastric disease.
Topics: Animals; Carcinoma, Squamous Cell; Horse Diseases; Horses; Omeprazole; Retrospective Studies; Stomac | 2024 |
Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice.
Topics: Adenocarcinoma; Animals; Anti-Ulcer Agents; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibi | 2009 |
Refractory ulcer of reconstructed gastric tube after esophagectomy: a case report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Carcinoma, Squamous Cell; Cy | 2013 |